Condition
Refractory T-Cell Non-Hodgkin Lymphoma clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Refractory T-Cell Non-Hodgkin Lymphoma clinical trials that are recruiting, in United States. By phase: Phase 1/2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Pralatrexate and bendamustine with total‑body radiation before donor stem cell transplant for relapsed or refractory T‑cell lymphoma
This trial tests whether giving pralatrexate and bendamustine together with total‑body radiation before a donor stem cell transplant helps adults with relapsed or refractory T‑cell non‑Hodgkin lymphoma.
-
Vaccine treatment for relapsed or refractory blood cancers
This study is testing a new vaccine treatment for people with relapsed or hard-to-treat blood cancers to see if it can help them feel better and live longer.
Related topics
Quick answers
How many Refractory T-Cell Non-Hodgkin Lymphoma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.